SCHEMBL9198531

SCHEMBL9198531

CCC1CCCCN1C(=O)c1c(-c2ccccc2)nn2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.62
LMNA P02545 2/20 0.62
ADORA2A P29274 2/20 0.55
ADORA2B P29275 2/20 0.55
ADORA3 P0DMS8 1/20 0.55
ADORA1 P30542 1/20 0.55
DAGLA Q9Y4D2 3/20 0.50
EGFR P00533 1/20 0.50
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
ABHD11 Q8NFV4 1/20 0.45
TP53 P04637 1/20 0.44
HPGD P15428 3/20 0.43
POLB P06746 1/20 0.43
ATM Q13315 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9454551 0.88 ADORA2A (0.50) L3MBTL1LMNAADORA2AADORA2BADORA3
SCHEMBL9199713 0.87 ADORA2A (0.57) L3MBTL1LMNAADORA2AADORA2BADORA3
SCHEMBL9199707 0.87 ADORA2A (0.57) L3MBTL1LMNAADORA2AADORA2BADORA3
SCHEMBL9199780 0.82 NPC1 (0.54) L3MBTL1LMNAADORA2AADORA2BADORA3
SCHEMBL9199652 0.81 ADORA2A (0.81) L3MBTL1LMNAADORA2AADORA2BADORA3
SCHEMBL9199146 0.81 ADORA2A (0.81) L3MBTL1LMNAADORA2AADORA2BADORA3
SCHEMBL9199656 0.81 ADORA2A (0.81) L3MBTL1LMNAADORA2AADORA2BADORA3
SCHEMBL9193574 0.81 ADORA2A (0.81) L3MBTL1LMNAADORA2AADORA2BADORA3
SCHEMBL22767740 0.81 ADORA2A (0.47) L3MBTL1LMNAADORA2AADORA2BADORA3
SCHEMBL9199141 0.81 ADORA2A (0.81) L3MBTL1LMNAADORA2AADORA2BADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0299209-B1 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1995-09-13 EP disclosed
EP-0387196-B1 Complexes with optically active ligands, process for their preparation and their use CIBA GEIGY AG (CH) 1995-05-03 EP disclosed
US-5296490-A Pharmaceutically useful pyrazolopyridines FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-03-22 US disclosed
US-5179103-A Diuretics, hypotensive agents FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1993-01-12 US disclosed
US-5102878-A Treating psychological, bone, cardiovascular, blood disorders FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-07 US disclosed
US-5102869-A Urogenital disorders FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-07 US disclosed
US-5087629-A Diuretics, hypotensive agents; cardiotonic agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-02-11 US disclosed
US-4994453-A Treating asthma, diabetes, obesity, immunosuppression FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-02-19 US disclosed
EP-0387196-A1 Complexes with optically active ligands, process for their preparation and their use CIBA-GEIGY AG (CH) 1990-09-12 EP disclosed
US-4925849-A DIURETICS, HYPOTENSIVE AGENTS, CARIOTONIC AGENTS AND ANTIEDEMIC AGENTS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-05-15 US disclosed
EP-0299209-A2 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-18 EP disclosed